Skip to Content
IRS Whistleblowers, click here to contact the Ways & Means Committee about waste, fraud, and abuse.

Hearing on Examining Chronic Drug Shortages in the United States

February 6, 2024 — Hearing   

Hearing Information
Tuesday, February 6, 2024 at 10:00 AM.
1100 Longworth House Office Building


Witness List:

Dr. Stephen Schleicher, MD, MBA
Chief Medical Officer, Tennessee Oncology
Witness Statement

Eugene Cavacini
Senior Vice President and Chief Operating Officer, McKesson Pharmaceutical Solutions & Services (PSaS)
Witness Statement

Allan Coukell, BSc
Senior Vice President for Public Policy, Civica Rx
Witness Statement

Dr. Stephen Schondelmeyer, PharmD, PhD
Director of the PRIME Institute, University of Minnesota’s College of Pharmacy
Witness Statement

Dr. Julie Gralow, MD
Chief Medical Officer and Executive Vice President, ASCO
Witness Statement

Dr. Jeromie Ballreich
PhD Associate Research Professor, Johns Hopkins Bloomberg School of Public Health
Witness Statement

SUBCOMMITTEE: Full Committee